(Q50707123)

English

Metformin improves skin capillary reactivity in normoglycaemic subjects with the metabolic syndrome.

scientific article published in March 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17263761

Metformin improves skin capillary reactivity in normoglycaemic subjects with the metabolic syndrome. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17263761

metabolic syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Kraemer de Aguiar LG

1

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17263761

Laflor CM

2

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17263761

Bahia L

3

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17263761

Villela NR

4

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17263761

Wiernsperger N

5

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17263761

Bottino DA

6

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17263761

Bouskela E

7

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17263761

publication date

1 March 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17263761

Diabetic Medicine

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17263761

24

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17263761

3

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17263761

272-279

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17263761

Endothelial dysfunction: cause of the insulin resistance syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02082.X

21 January 2018

Metformin improves vascular function in insulin-resistant rats.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02082.X

21 January 2018

Coronary vasomotor abnormalities in insulin-resistant individuals

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02082.X

21 January 2018

The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02082.X

21 January 2018

Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1074/JBC.M404421200

Identifiers

10.1111/J.1464-5491.2007.02082.X

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17263761

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/17263761

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50707123&oldid=2041472194"